Concourse Financial Group Securities, Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
22,167
Total Value
0
Accession Number
0000752798-25-000010
Form Type
13F-HR
Manager Name
Concourse Financial Group Securities, Inc.
Data Enrichment
23% identified
5,188 identified16,979 unidentified

Holdings

22,167 positions
Manager:
Search and click to pin securities to the top
Page 15 of 1109
Xeris Biopharma Holdings, Inc.
Shares:
0
Value:
$0
Axsome Therapeutics, Inc.
Shares:
0
Value:
$0
Alignment Healthcare, Inc.
Shares:
0
Value:
$0
Centessa Pharmaceuticals plc
Shares:
0
Value:
$0
SOLENO THERAPEUTICS INC
Shares:
0
Value:
$0
Akero Therapeutics, Inc.
Shares:
0
Value:
$0
Trevi Therapeutics, Inc.
Shares:
0
Value:
$0
Arcutis Biotherapeutics, Inc.
Shares:
0
Value:
$0
Alkermes plc.
Shares:
0
Value:
$0
HALOZYME THERAPEUTICS, INC.
Shares:
0
Value:
$0(-100.0%)
NewAmsterdam Pharma Co N.V.
Shares:
0
Value:
$0
Krystal Biotech, Inc.
Shares:
0
Value:
$0
Edgewise Therapeutics, Inc.
Shares:
0
Value:
$0
Kiniksa Pharmaceuticals International, plc
Shares:
0
Value:
$0
BridgeBio Pharma, Inc.
Shares:
0
Value:
$0
NEKTAR THERAPEUTICS
Shares:
0
Value:
$0
Merus N.V.
Shares:
0
Value:
$0
Protagonist Therapeutics, Inc
Shares:
0
Value:
$0
07725L102
Shares:
0
Value:
$0
Shares:
0
Value:
$0(-100.0%)